These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Secondary prevention of coronary artery disease with lipid-lowering drugs]. Delahaye F; De Gevigney G Ann Med Interne (Paris); 2001 Apr; 152(3):184-7. PubMed ID: 11431578 [TBL] [Abstract][Full Text] [Related]
29. Halofenate: an effective hypolipemia- and hypouricemia-inducing drug. Aronow WS; Vangrow JS; Nelson WH; Pagano J; Papageorge's NP; Khursheed M; Harding PR; Khemka M Curr Ther Res Clin Exp; 1973 Dec; 15(12):902-6. PubMed ID: 4203573 [No Abstract] [Full Text] [Related]
30. [Also elderly patients with hyperlipidemia and coronary disease need lipid lowering agents]. Hellénius ML Lakartidningen; 2001 Sep; 98(39):4188-90. PubMed ID: 11680152 [No Abstract] [Full Text] [Related]
31. [The diagnosis and treatment of coronary heart disease in chronic renal failure]. Belialov FI Klin Med (Mosk); 2004; 82(10):8-12. PubMed ID: 15584591 [No Abstract] [Full Text] [Related]
32. [Analysis of reasons for discontinuation of treatment for dyslipidemia in secondary prevention of coronary heart disease]. Tyszecka G Przegl Lek; 1999; 56(11):709-15. PubMed ID: 10800583 [TBL] [Abstract][Full Text] [Related]
33. Dyslipidaemia and coronary heart disease: nature vs nurture. Hegele RA Br J Hosp Med; 1995 Aug 16-Sep 5; 54(4):143-6. PubMed ID: 7582364 [TBL] [Abstract][Full Text] [Related]
35. Are the massive diet fat-heart and coronary drug studies justified? A critical commentary. Roberts HJ Angiology; 1968 Dec; 19(12):652-64. PubMed ID: 4882422 [No Abstract] [Full Text] [Related]
36. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative. Oriente P; Motolese M; Cerqua R; Mancini M Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988 [No Abstract] [Full Text] [Related]
37. Management of dyslipidemia in adults. Ahmed SM; Clasen ME; Donnelly JE Am Fam Physician; 1998 May; 57(9):2192-2204, 2207-8. PubMed ID: 9606309 [TBL] [Abstract][Full Text] [Related]
38. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?]. Kolenda KD Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107 [No Abstract] [Full Text] [Related]
39. Effectiveness of antihyperlipidemic drug management in clinical practice. Andrade SE; Saperia GM; Berger ML; Platt R Clin Ther; 1999 Nov; 21(11):1973-87. PubMed ID: 10890267 [TBL] [Abstract][Full Text] [Related]
40. [Role of lipemia-lowering agents in the secondary prevention of myocardial infarct]. Tullio D Clin Ter; 1986 Feb; 116(3):221-35. PubMed ID: 3516543 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]